| Year |
Citation |
Score |
| 2021 |
Resnick D, Morales K, Gross R, Petsis D, Fiore D, Davis-Vogel A, Metzger D, Frank I, Wood S. Prior Sexually Transmitted Infection and Human Immunodeficiency Virus Risk Perception in a Diverse At-Risk Population of Men Who Have Sex with Men and Transgender Individuals. Aids Patient Care and Stds. 35: 15-22. PMID 33400589 DOI: 10.1089/apc.2020.0179 |
0.323 |
|
| 2020 |
Bauer AM, Hosie Quinn M, Lubitz SF, Flitter A, Ashare RL, Leone FT, Gross R, Hitsman B, Schnoll R. Medication adherence and rate of nicotine metabolism are associated with response to treatment with varenicline among smokers with HIV. Addictive Behaviors. 112: 106638. PMID 32911350 DOI: 10.1016/J.Addbeh.2020.106638 |
0.313 |
|
| 2020 |
Wood SM, Morales KH, Metzger D, Davis A, Fiore D, Petsis D, Barnett K, Koenig HC, Dowshen N, Gross R, Frank I. Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials. Aids and Behavior. PMID 32860114 DOI: 10.1007/S10461-020-03004-Y |
0.336 |
|
| 2020 |
Ashare RL, Bernstein SL, Schnoll R, Gross R, Catz SL, Cioe P, Crothers K, Hitsman B, Marhefka SL, McClure JB, Pacek LR, Vidrine DJ, Vilardaga R, Kaufman A, Edelman EJ. The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 32803251 DOI: 10.1093/Ntr/Ntaa155 |
0.362 |
|
| 2020 |
Lowenthal E, Matesva M, Marukutira T, Bayani O, Chapman J, Tshume O, Matshaba M, Hickson M, Gross R. Psychological Reactance is a Novel Risk Factor for Adolescent Antiretroviral Treatment Failure. Aids and Behavior. PMID 32754779 DOI: 10.1007/S10461-020-02986-Z |
0.306 |
|
| 2020 |
Ashare RL, Wileyto EP, Logue-Chamberlain E, Gross R, Tyndale RF, Lerman C, Hawk LW, Cinciripini P, George TP, Lubitz SF, Schnoll R. Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 32686950 DOI: 10.1037/Adb0000619 |
0.429 |
|
| 2020 |
Tsima BM, Moedi P, Maunge J, Machangane K, Kgogwane M, Mudojwa T, Bastian J, Bilker W, Ashare R, Schnoll R, Gross R. Feasibility of implementing a novel behavioural smoking cessation intervention amongst human immunodeficiency virus-infected smokers in a resource-limited setting: A single-arm pilot trial. Southern African Journal of Hiv Medicine. 21: 1075. PMID 32670627 DOI: 10.4102/Sajhivmed.V21I1.1075 |
0.351 |
|
| 2020 |
Okatch H, Morales K, Rogers R, Chapman J, Marukutira T, Tshume O, Matshaba M, Gross R, Lowenthal ED. Trends in HIV Treatment Adherence Before and After HIV Status Disclosure to Adolescents in Botswana. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 32340848 DOI: 10.1016/J.Jadohealth.2020.02.023 |
0.41 |
|
| 2020 |
Garza R, Gill AJ, Bastien BL, Garcia-Mesa Y, Gruenewald AL, Gelman BB, Tsima B, Gross R, Letendre SL, Kolson DL. Heme oxygenase-1 promoter (GT) polymorphism associates with HIV neurocognitive impairment. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32277015 DOI: 10.1212/Nxi.0000000000000710 |
0.36 |
|
| 2020 |
Wimberly AS, Gross R, Layde M. Effect of Yoga on Antiretroviral Adherence Postincarceration in HIV+ Individuals. Journal of Correctional Health Care : the Official Journal of the National Commission On Correctional Health Care. 26: 83-94. PMID 32089078 DOI: 10.1177/1078345819897924 |
0.396 |
|
| 2020 |
Thompson M, Schnoll R, Serrano K, Leone F, Gross R, Collman RG, Ashare RL. The effect of varenicline on mood and cognition in smokers with HIV. Psychopharmacology. PMID 31938877 DOI: 10.1007/S00213-020-05451-W |
0.313 |
|
| 2020 |
Martei YM, Grover S, Narasimhamurthy M, Setlhako DII, Ayane GN, Ralefala TB, Chiyapo SP, Gross R, DeMichele A, Shulman LN. Relative dose intensity and pathologic response rates in HIV-infected and HIV-uninfected breast cancer patients who received neoadjuvant chemotherapy. Journal of Clinical Oncology. 38: e19140-e19140. DOI: 10.1200/Jco.2020.38.15_Suppl.E19140 |
0.429 |
|
| 2019 |
Lubitz SF, Flitter A, Ashare RL, Thompson M, Leone F, Gross R, Schnoll R. Improved clinical outcomes among persons with HIV who quit smoking. Aids Care. 1-7. PMID 31847536 DOI: 10.1080/09540121.2019.1703891 |
0.305 |
|
| 2019 |
Ghura S, Gross R, Jordan-Sciutto K, Dubroff J, Schnoll R, Collman RG, Ashare RL. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 31834620 DOI: 10.1007/S11481-019-09897-4 |
0.344 |
|
| 2019 |
Quinn MH, Bauer AM, Flitter A, Lubitz SF, Ashare RL, Thompson M, Leone F, Gross R, Schnoll R. Correlates of varenicline adherence among smokers with HIV and its association with smoking cessation. Addictive Behaviors. 102: 106151. PMID 31783245 DOI: 10.1016/J.Addbeh.2019.106151 |
0.375 |
|
| 2019 |
Wallis CL, Hughes MD, Ritz J, Viana R, Silva de Jesus C, Saravanan S, van Schalkwyk M, Mngqibisa R, Salata R, Mugyenyi P, Hogg E, Hovind L, Wieclaw L, Gross R, Godfrey C, et al. Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31724034 DOI: 10.1093/Cid/Ciz1116 |
0.361 |
|
| 2019 |
Wood S, Dowshen N, Bauermeister JA, Lalley-Chareczko L, Franklin J, Petsis D, Swyryn M, Barnett K, Weissman GE, Koenig HC, Gross R. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 31672523 DOI: 10.1016/J.Jadohealth.2019.08.014 |
0.318 |
|
| 2019 |
Grinsztejn B, Hughes MD, Ritz J, Salata R, Mugyenyi P, Hogg E, Wieclaw L, Gross R, Godfrey C, Cardoso SW, Bukuru A, Makanga M, Faesen S, Mave V, Wangari Ndege B, et al. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. The Lancet. Hiv. PMID 31371262 DOI: 10.1016/S2352-3018(19)30146-8 |
0.315 |
|
| 2019 |
Brickman C, Propert K, Merlin J, Liu J, Eady S, McGhee-Jez A, Ragin C, Grover S, Cohen R, Gross R. Treatment and Outcomes of Oropharyngeal Cancer in Patients with Human Immunodeficiency Virus. Aids Research and Human Retroviruses. PMID 31347379 DOI: 10.1089/Aid.2019.0009 |
0.393 |
|
| 2019 |
Ghose T, Shubert V, Poitevien V, Choudhuri S, Gross R. Effectiveness of a Viral Load Suppression Intervention for Highly Vulnerable People Living with HIV. Aids and Behavior. PMID 31098747 DOI: 10.1007/S10461-019-02509-5 |
0.36 |
|
| 2019 |
Ashare RL, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Collman RG, Wileyto EP, Schnoll R. Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV. Drug and Alcohol Dependence. 200: 26-33. PMID 31082665 DOI: 10.1016/J.Drugalcdep.2019.03.011 |
0.369 |
|
| 2019 |
Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, Swyryn M, Lalley-Chareczko L, Koenig HC, Dowshen N. Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color. Aids and Behavior. PMID 30993479 DOI: 10.1007/S10461-019-02502-Y |
0.4 |
|
| 2019 |
Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). 33: 1083-1088. PMID 30946162 DOI: 10.1097/Qad.0000000000002127 |
0.371 |
|
| 2019 |
Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, et al. Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial. The Lancet. Hiv. PMID 30880163 DOI: 10.1016/S2352-3018(18)30362-X |
0.375 |
|
| 2019 |
Wood S, Dowshen N, Bauermeister JA, Lally-Chareczko L, Franklin J, Petsis DT, Swyryn M, Koenig HC, Gross R. 31. Characteristics of Social Support Networks Among Young Men And Transgender Women of Color Receiving Pre-Exposure Prophylaxis (PrEP) For HIV Prevention Journal of Adolescent Health. 64: S16-S17. DOI: 10.1016/J.Jadohealth.2018.10.045 |
0.323 |
|
| 2018 |
Schnoll RA, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Mounzer K, Tyndale RF, Weisbrot J, Meline M, Collman RG, Ashare RL. Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30399039 DOI: 10.1097/Qai.0000000000001895 |
0.309 |
|
| 2018 |
Genn L, Chapman J, Okatch H, Abell N, Marukutira T, Tshume O, Anabwani G, Gross R, Lowenthal ED. Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana. Aids and Behavior. PMID 30387024 DOI: 10.1007/S10461-018-2325-9 |
0.368 |
|
| 2018 |
Torgersen J, Bellamy SL, Ratshaa B, Han X, Mosepele M, Zuppa AF, Vujkovic M, Steenhoff AP, Bisson GP, Gross R. Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans. European Journal of Drug Metabolism and Pharmacokinetics. PMID 30168000 DOI: 10.1007/S13318-018-0507-5 |
0.319 |
|
| 2018 |
Vujkovic M, Bellamy SL, Zuppa AF, Gastonguay MR, Moorthy GS, Ratshaa B, Han X, Steenhoff AP, Mosepele M, Strom BL, Bisson GP, Aplenc R, Gross R. Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana. The Pharmacogenomics Journal. PMID 29855606 DOI: 10.1038/S41397-018-0028-2 |
0.318 |
|
| 2018 |
Merlin JS, Long D, Becker WC, Cachay ER, Christopolous KA, Claborn K, Crane HM, Edelman EJ, Harding R, Kertesz SG, Liebschutz JM, Mathews WC, Mugavero MJ, Napravnik S, O'Cleirigh C, ... ... Gross R, et al. The Association of Chronic Pain and Long-Term Opioid Therapy with HIV Treatment Outcomes. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29771793 DOI: 10.1097/Qai.0000000000001741 |
0.363 |
|
| 2018 |
Tsima B, Ratcliffe SJ, Schnoll R, Frank I, Kolson DL, Gross R. Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV? Journal of the International Association of Providers of Aids Care. 17: 2325958218768018. PMID 29667531 DOI: 10.1177/2325958218768018 |
0.418 |
|
| 2018 |
Harris RA, Haberer JE, Musinguzi N, Chang KM, Schechter CB, Doubeni CA, Gross R. Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model. Plos One. 13: e0194713. PMID 29566096 DOI: 10.1371/Journal.Pone.0194713 |
0.391 |
|
| 2018 |
Wood S, Ratcliffe S, Gowda C, Lee S, Dowshen NL, Gross R. Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV. Aids (London, England). PMID 29424777 DOI: 10.1097/Qad.0000000000001772 |
0.424 |
|
| 2017 |
Coppock D, Zambo D, Moyo D, Tanthuma G, Chapman J, Re VL, Graziani A, Lowenthal E, Hanrahan N, Littman-Quinn R, Kovarik C, Albarracin D, Holmes JH, Gross R. Development and Usability of a Smartphone Application for Tracking Antiretroviral Medication Refill Data for Human Immunodeficiency Virus. Methods of Information in Medicine. 56: 351-359. PMID 29582932 DOI: 10.3414/Me17-01-0045 |
0.342 |
|
| 2017 |
Mosepele M, Letsatsi V, Mokgatlhe L, Hudson FP, Gross R. Cholesterol Screening and Statin Prescription is Low Among HIV-Infected Patients on Protease-Inhibitor Regimens in Botswana. The Open Aids Journal. 11: 45-51. PMID 28839514 DOI: 10.2174/1874613601711010045 |
0.392 |
|
| 2017 |
Lo Re Rd V, Zeldow B, Kallan MJ, Tate JP, Carbonari DM, Hennessy S, Kostman JR, Lim JK, Goetz MB, Gross R, Justice AC, Roy JA. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection. Pharmacoepidemiology and Drug Safety. PMID 28722244 DOI: 10.1002/Pds.4258 |
0.322 |
|
| 2017 |
Gross R, Bellamy SL, Ratshaa B, Han X, Vujkovic M, Aplenc R, Steenhoff AP, Mosepele M, Moorthy G, Zuppa AF, Strom BL, Bisson GP. CYP2B6 genotypes and early efavirenz-based hiv treatment outcomes in botswana. Aids (London, England). PMID 28692529 DOI: 10.1097/Qad.0000000000001593 |
0.394 |
|
| 2017 |
Vujkovic M, Bellamy SL, Zuppa AF, Gastonguay M, Moorthy GS, Ratshaa BR, Han X, Steenhoff AP, Mosepele M, Strom BL, Aplenc R, Bisson GP, Gross R. CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-treated HIV-Infected Patients in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28481785 DOI: 10.1097/Qai.0000000000001442 |
0.359 |
|
| 2017 |
Harrison JD, Dochney JA, Blazekovic S, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Siegel S, Schnoll RA, Ashare RL. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. Journal of Neurovirology. PMID 28429289 DOI: 10.1007/S13365-017-0526-Z |
0.41 |
|
| 2017 |
Ravimohan S, Tamuhla N, Nfanyana K, Ni H, Steenhoff AP, Gross R, Weissman D, Bisson GP. Elevated pre-ART CD39+CD8+ T-cell frequency is associated with early mortality in advanced HIV/TB. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28203772 DOI: 10.1093/Cid/Cix155 |
0.303 |
|
| 2017 |
Mauk M, Song J, Bau HH, Gross R, Bushman FD, Collman RG, Liu C. Miniaturized devices for point of care molecular detection of HIV. Lab On a Chip. PMID 28092381 DOI: 10.1039/C6Lc01239F |
0.402 |
|
| 2016 |
Jones HB, Gross R. HIV/AIDS KNOWLEDGE AND PRIOR TESTING AT 'AFRICA GOAL' OUTREACH EVENTS IN EAST AND SOUTHERN AFRICA. African Journal of Infectious Diseases. 10: 118-120. PMID 28480446 DOI: 10.21010/Ajid.V10I2.7 |
0.392 |
|
| 2016 |
Brickman C, Propert KJ, Voytek C, Metzger D, Gross R. Association Between Depression and Condom Use Differs by Sexual Behavior Group in Patients with HIV. Aids and Behavior. PMID 27878639 DOI: 10.1007/S10461-016-1610-8 |
0.354 |
|
| 2016 |
Gowda C, Coppock D, Brickman C, Shaw PA, Gross R. Determinants of HIV Transmission Risk Among HIV-Infected Persons Engaged in Care. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 28: 440-452. PMID 27710086 DOI: 10.1521/Aeap.2016.28.5.440 |
0.432 |
|
| 2016 |
Ioannides KL, Chapman J, Marukutira T, Tshume O, Anabwani G, Gross R, Lowenthal ED. Patterns of HIV Treatment Adherence do not Differ Between Male and Female Adolescents in Botswana. Aids and Behavior. PMID 27631365 DOI: 10.1007/S10461-016-1530-7 |
0.34 |
|
| 2016 |
Gross R, Bellamy SL, Ratshaa B, Han X, Steenhoff AP, Mosepele M, Bisson GP. Effects of Sex and Alcohol Use on Antiretroviral Therapy Outcomes in Botswana: A Cohort Study. Addiction (Abingdon, England). PMID 27447841 DOI: 10.1111/Add.13538 |
0.309 |
|
| 2016 |
Ravimohan S, Tamuhla N, Kung SJ, Nfanyana K, Steenhoff AP, Gross R, Weissman D, Bisson GP. Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy. Ebiomedicine. 3: 100-7. PMID 27014741 DOI: 10.1016/J.Ebiom.2015.11.040 |
0.322 |
|
| 2016 |
Okatch H, Beiter K, Eby J, Chapman J, Marukutira T, Tshume O, Matshaba M, Anabwani GM, Gross R, Lowenthal E. Brief Report: Apparent Antiretroviral Over-adherence by Pill Count is Associated with HIV Treatment Failure in Adolescents. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26990822 DOI: 10.1097/Qai.0000000000000994 |
0.425 |
|
| 2016 |
Bonacci RA, Frasca K, Swift L, Sha D, Bilker WB, Bamford L, Yehia BR, Gross R. Antiretroviral Refill Adherence Correlates with, But Poorly Predicts Retention in HIV Care. Aids and Behavior. 20: 1060-7. PMID 26400078 DOI: 10.1007/S10461-015-1205-9 |
0.395 |
|
| 2016 |
Torgersen J, Zuppa A, Bellamy S, Han X, Bisson GP, Gross R. Does Slow Efavirenz Metabolism Have Greater Impact on Outcomes of Older HIV+ Africans? Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1222 |
0.37 |
|
| 2015 |
De Boni RB, Zheng L, Rosenkranz SL, Sun X, Lavenberg J, Cardoso SW, Grinsztejn B, La Rosa A, Pierre S, Severe P, Cohn SE, Collier AC, Gross R. Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals. Drug and Alcohol Dependence. PMID 26774947 DOI: 10.1016/J.Drugalcdep.2015.12.013 |
0.402 |
|
| 2015 |
Eby J, Chapman J, Marukutira T, Anabwani G, Tshume O, Lepodisi O, Dipotso T, Mokete K, Gross R, Lowenthal E. The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data. Pharmacoepidemiology and Drug Safety. PMID 26456482 DOI: 10.1002/Pds.3887 |
0.371 |
|
| 2015 |
Gross R, Zheng L, Rosa AL, Sun X, Rosenkranz SL, Cardoso SW, Ssali F, Camp R, Godfrey C, Cohn SE, Robbins GK, Chisada A, Wallis CL, Reynolds NR, Lu D, et al. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial. The Lancet. Hiv. 2: e12-9. PMID 26424232 DOI: 10.1016/S2352-3018(14)00007-1 |
0.369 |
|
| 2015 |
Lyons A, Bilker WB, Hines J, Gross R. Effect of format on comprehension of adherence data in chronic disease: A cross-sectional study in HIV. Patient Education and Counseling. PMID 26324110 DOI: 10.1016/J.Pec.2015.08.002 |
0.339 |
|
| 2015 |
Petersen ML, LeDell E, Schwab J, Sarovar V, Gross R, Reynolds N, Haberer JE, Goggin K, Golin C, Arnsten J, Rosen MI, Remien RH, Etoori D, Wilson IB, Simoni JM, et al. Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 109-18. PMID 25942462 DOI: 10.1097/Qai.0000000000000548 |
0.397 |
|
| 2015 |
Yehia BR, Stephens-Shield AJ, Momplaisir F, Taylor L, Gross R, Dubé B, Glanz K, Brady KA. Health Outcomes of HIV-Infected People with Mental Illness. Aids and Behavior. PMID 25931243 DOI: 10.1007/S10461-015-1080-4 |
0.415 |
|
| 2015 |
Lowenthal ED, Marukutira T, Tshume O, Chapman J, Anabwani GM, Gross R. Prediction of HIV Virologic Failure Among Adolescents Using the Pediatric Symptom Checklist. Aids and Behavior. PMID 25855047 DOI: 10.1007/S10461-015-1061-7 |
0.384 |
|
| 2015 |
Lowenthal ED, Marukutira T, Tshume O, Chapman J, Nachega JB, Anabwani G, Gross R. Parental absence from clinic predicts human immunodeficiency virus treatment failure in adolescents. Jama Pediatrics. 169: 498-500. PMID 25822083 DOI: 10.1001/Jamapediatrics.2014.3785 |
0.335 |
|
| 2015 |
Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Nfanyana K, Bellamy SL, MacGregor RR, Gross R, Weissman D, Bisson GP. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. The Lancet. Infectious Diseases. 15: 429-38. PMID 25672566 DOI: 10.1016/S1473-3099(15)70008-3 |
0.354 |
|
| 2015 |
Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, Mounzer K, Samuel R, Metlay JP, Yehia BR. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. Aids Care. 27: 817-28. PMID 25671515 DOI: 10.1080/09540121.2015.1009362 |
0.402 |
|
| 2015 |
Gross R, Bandason T, Langhaug L, Mujuru H, Lowenthal E, Ferrand R. Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. Aids Care-Psychological and Socio-Medical Aspects of Aids\/Hiv. 27: 322-326. PMID 25338010 DOI: 10.1080/09540121.2014.969676 |
0.392 |
|
| 2014 |
Mills EJ, Lester R, Thorlund K, Lorenzi M, Muldoon K, Kanters S, Linnemayr S, Gross R, Calderon Y, Amico KR, Thirumurthy H, Pearson C, Remien RH, Mbuagbaw L, Thabane L, et al. Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysis. The Lancet. Hiv. 1: e104-11. PMID 26424119 DOI: 10.1016/S2352-3018(14)00003-4 |
0.389 |
|
| 2014 |
Liu C, Sadik MM, Mauk MG, Edelstein PH, Bushman FD, Gross R, Bau HH. Nuclemeter: a reaction-diffusion based method for quantifying nucleic acids undergoing enzymatic amplification. Scientific Reports. 4: 7335. PMID 25477046 DOI: 10.1038/Srep07335 |
0.312 |
|
| 2014 |
Simoni JM, Huh D, Wang Y, Wilson IB, Reynolds NR, Remien RH, Goggin K, Gross R, Rosen MI, Schneiderman N, Arnsten J, Golin CE, Erlen JA, Bangsberg DR, Liu H. The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. Aids and Behavior. 18: 2285-90. PMID 25280447 DOI: 10.1007/S10461-014-0905-X |
0.361 |
|
| 2014 |
Lowenthal ED, Marukutira TC, Chapman J, Mokete K, Riva K, Tshume O, Eby J, Matshaba M, Anabwani GM, Gross R, Glanz K. Psychosocial Assessments for HIV+ African Adolescents: Establishing Construct Validity and Exploring Under-Appreciated Correlates of Adherence Plos One. 9. PMID 25279938 DOI: 10.1371/Journal.Pone.0109302 |
0.355 |
|
| 2014 |
Hafkin JS, Osborn MK, Localio AR, Amorosa VK, Kostman JR, Stern JJ, De La Torre P, Mounzer K, Frank I, Gross R, Chang KM, Lo Re V. Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. Journal of Viral Hepatitis. 21: 288-96. PMID 24597697 DOI: 10.1111/Jvh.12142 |
0.372 |
|
| 2014 |
Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, Gallant JE, Mugavero MJ, Mills EJ, Giordano TP. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1297-307. PMID 24457345 DOI: 10.1093/Cid/Ciu046 |
0.363 |
|
| 2014 |
Remien RH, Dolezal C, Wagner GJ, Goggin K, Wilson IB, Gross R, Rosen MI, Shen J, Simoni JM, Golin CE, Arnsten JH, Bangsberg DR, Liu H. The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention. Aids and Behavior. 18: 1541-7. PMID 24213215 DOI: 10.1007/S10461-013-0656-0 |
0.357 |
|
| 2014 |
Yehia BR, Schranz AJ, Momplaisir F, Keller SC, Gross R, Frank I, Metlay JP, Brady KA. Outcomes of HIV-infected patients receiving care at multiple clinics. Aids and Behavior. 18: 1511-22. PMID 24077931 DOI: 10.1007/S10461-013-0625-7 |
0.406 |
|
| 2014 |
Bamford L, Ellenberg JH, Hines J, Vinnard C, Jasani A, Gross R. Factors associated with a willingness to accept rapid HIV testing in an urban emergency department. Aids and Behavior. 18: 250-3. PMID 23536139 DOI: 10.1007/S10461-013-0452-X |
0.416 |
|
| 2013 |
Wilson IB, Bangsberg DR, Shen J, Simoni JM, Reynolds NR, Goggin K, Gross R, Arnsten JH, Remien RH, Erlen JA, Liu H. Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. Journal of Acquired Immune Deficiency Syndromes (1999). 64: 448-54. PMID 24225904 DOI: 10.1097/Qai.0000000000000025 |
0.422 |
|
| 2013 |
Ndiaye M, Nyasulu P, Nguyen H, Lowenthal ED, Gross R, Mills EJ, Nachega JB. Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: A pilot cross-sectional study Patient Preference and Adherence. 7: 891-895. PMID 24049440 DOI: 10.2147/Ppa.S47628 |
0.406 |
|
| 2013 |
Gross R, Bellamy SL, Strom BL. Reply: To PMID 23358784. Jama Internal Medicine. 173: 1475-6. PMID 23939524 DOI: 10.1001/Jamainternmed.2013.7782 |
0.318 |
|
| 2013 |
Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, et al. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis. The Journal of Infectious Diseases. 208: 1784-93. PMID 23908475 DOI: 10.1093/Infdis/Jit368 |
0.35 |
|
| 2013 |
Lowenthal ED, Ellenberg JH, Machine E, Sagdeo A, Boiditswe S, Steenhoff AP, RMRMD, Anabwani G, Gross R. Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children Jama. 309: 1803-1809. PMID 23632724 DOI: 10.1001/Jama.2013.3710 |
0.405 |
|
| 2013 |
Amico KR, Zuniga JM, Wilson IB, Gross R, Young B. Provider guidance for linking patients to antiretroviral therapy adherence interventions: recommendations from an IAPAC advisory committee on adherence monitoring and support. Journal of the International Association of Providers of Aids Care. 12: 79-83. PMID 23520402 DOI: 10.1177/1545109712474844 |
0.368 |
|
| 2013 |
Gross R, Bellamy SL, Chapman J, Han X, O'Duor J, Palmer SC, Houts PS, Coyne JC, Strom BL. Managed problem solving for antiretroviral therapy adherence: a randomized trial. Jama Internal Medicine. 173: 300-6. PMID 23358784 DOI: 10.1001/Jamainternmed.2013.2152 |
0.352 |
|
| 2013 |
Lo Re V, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R. Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients. Aids and Behavior. 17: 94-103. PMID 22907288 DOI: 10.1007/S10461-012-0288-9 |
0.375 |
|
| 2013 |
Liu H, Wilson IB, Goggin K, Reynolds N, Simoni JM, Golin CE, Rosen MI, Gross R, Wagner G, Remien RH, Schneiderman N, Erlen JA, Arnsten JH, Bangsberg DR. MACH14: a multi-site collaboration on ART adherence among 14 institutions. Aids and Behavior. 17: 127-41. PMID 22864921 DOI: 10.1007/S10461-012-0272-4 |
0.329 |
|
| 2013 |
Mills E, Nachega J, Lester R, Thorlund K, Ioannidis J, Linnemayr S, Gross R, Calderone Y, Amico R, Thirumurthy H, Pearson C, Remien R, Mbuagbaw L, Thabane L, Chung M, et al. Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings: An Individual Patient Data Network Meta-Analysis Value in Health. 16: A361. DOI: 10.1016/J.Jval.2013.08.223 |
0.313 |
|
| 2013 |
Merlin J, Westfall A, Raper J, Zinski A, Norton W, Willig J, Gross R, Ritchie C, Saag M, Mugavero M. Pain, Mood, and Substance Abuse in HIV: Implications for Clinic Visit Utilization, ART Adherence, and Virologic Failure (S701) Journal of Pain and Symptom Management. 45: 416. DOI: 10.1016/J.Jpainsymman.2012.10.118 |
0.373 |
|
| 2012 |
Reid MJA, Mosepele M, Tsima BM, Gross R. Addressing the challenge of the emerging NCD epidemic: lessons learned from Botswana's response to the HIV epidemic. Public Health Action. 2: 47-49. PMID 26392950 DOI: 10.5588/Pha.12.0014 |
0.407 |
|
| 2012 |
Steenhoff AP, Redwood A, Pettifor JM, Hove J, Bisson GP, Mosepele M, Pusoesele P, Thakur R, Kovarik C, Gross R. Vitamin D status in HIV-infected patients with and without tuberculosis: A pilot study Journal of Acquired Immune Deficiency Syndromes. 61. PMID 23007121 DOI: 10.1097/Qai.0B013E3182683Cd2 |
0.349 |
|
| 2012 |
Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, Simoni J, Gross R, Reynolds N, Rosen M, Liu H. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. Aids (London, England). 26: 1415-23. PMID 22767342 DOI: 10.1097/Qad.0B013E328354Bed6 |
0.437 |
|
| 2012 |
Merlin JS, Westfall AO, Raper JL, Zinski A, Norton WE, Willig JH, Gross R, Ritchie CS, Saag MS, Mugavero MJ. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 164-70. PMID 22766967 DOI: 10.1097/Qai.0B013E3182662215 |
0.325 |
|
| 2012 |
Azzoni L, Foulkes AS, Firnhaber C, Yin X, Xiang ZQ, Li Y, Stevens W, Gross R, Ertl HC, Sanne I, Montaner LJ. Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals. Aids (London, England). 26: 1355-62. PMID 22516873 DOI: 10.1097/Qad.0B013E328354648E |
0.39 |
|
| 2012 |
Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, Beckwith CG, Dowshen N, Gordon CM, Horn T, Kumar P, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Annals of Internal Medicine. 156: 817-33, W-284, W-285. PMID 22393036 DOI: 10.7326/0003-4819-156-11-201206050-00419 |
0.412 |
|
| 2012 |
Lowenthal E, Lawler K, Harari N, Moamogwe L, Masunge J, Masedi M, Matome B, Seloilwe E, Gross R. Rapid psychosocial function screening test identified treatment failure in HIV+ African youth. Aids Care. 24: 722-7. PMID 22292411 DOI: 10.1080/09540121.2011.644233 |
0.421 |
|
| 2011 |
Blank MB, Hanrahan NP, Fishbein M, Wu ES, Tennille JA, Ten Have TR, Kutney-Lee AM, Gross R, Hines JM, Coyne JC, Aiken LH. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Psychiatric Services (Washington, D.C.). 62: 1318-24. PMID 22211211 DOI: 10.1176/Ps.62.11.Pss6211_1318 |
0.397 |
|
| 2011 |
Firnhaber C, Azzoni L, Foulkes AS, Gross R, Yin X, Van Amsterdam D, Schulze D, Glencross DK, Stevens W, Hunt G, Morris L, Fox L, Sanne I, Montaner LJ. Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection. Plos One. 6: e21450. PMID 21738668 DOI: 10.1371/Journal.Pone.0021450 |
0.401 |
|
| 2011 |
Steele KT, Steenhoff AP, Newcomb CW, Rantleru T, Nthobatsang R, Lesetedi G, Bellamy SL, Nachega JB, Gross R, Bisson GP. Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana. Plos One. 6: e20010. PMID 21698283 DOI: 10.1371/Journal.Pone.0020010 |
0.389 |
|
| 2011 |
Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, Mills EJ, Gross R. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infectious Disorders Drug Targets. 11: 167-74. PMID 21406048 DOI: 10.2174/187152611795589663 |
0.393 |
|
| 2011 |
Harris J, Pillinger M, Fromstein D, Gomez B, Garris I, Kanetsky PA, Tebas P, Gross R. Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic. Aids and Behavior. 15: 1410-5. PMID 20721615 DOI: 10.1007/S10461-010-9781-1 |
0.388 |
|
| 2010 |
Azzoni L, Crowther NJ, Firnhaber C, Foulkes AS, Yin X, Glencross D, Gross R, Kaplan MD, Papasavvas E, Schulze D, Stevens W, van der Merwe T, Waisberg R, Sanne I, Montaner LJ. Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women. Journal of the International Aids Society. 13: 33. PMID 20822522 DOI: 10.1186/1758-2652-13-33 |
0.409 |
|
| 2010 |
Wilkin TJ, Su Z, Krambrink A, Long J, Greaves W, Gross R, Hughes MD, Flexner C, Skolnik PR, Coakley E, Godfrey C, Hirsch M, Kuritzkes DR, Gulick RM. Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients. Journal of Acquired Immune Deficiency Syndromes (1999). 54: 470-6. PMID 20672447 DOI: 10.1097/Qai.0B013E3181E2Cba0 |
0.392 |
|
| 2010 |
Acri TL, Grossberg RM, Gross R. How long is the right interval for assessing antiretroviral pharmacy refill adherence? Journal of Acquired Immune Deficiency Syndromes. 54. PMID 20647824 DOI: 10.1097/Qai.0B013E3181Ed1626 |
0.323 |
|
| 2010 |
Bachhuber M, Bilker WB, Wang H, Chapman J, Gross R. Is antiretroviral therapy adherence substantially worse on weekends than weekdays? Journal of Acquired Immune Deficiency Syndromes. 54: 109-110. PMID 20418726 DOI: 10.1097/Qai.0B013E3181Cbd34B |
0.425 |
|
| 2010 |
Flexner C, Tierney C, Gross R, Andrade A, Lalama C, Eshleman SH, Aberg J, Sanne I, Parsons T, Kashuba A, Rosenkranz SL, Kmack A, Ferguson E, Dehlinger M, Mildvan D, et al. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1041-52. PMID 20192725 DOI: 10.1086/651118 |
0.363 |
|
| 2010 |
Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Laskin MS, Kimmel SE. Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest. 137: 883-9. PMID 19903973 DOI: 10.1378/Chest.09-0039 |
0.304 |
|
| 2010 |
Acri T, TenHave TR, Chapman JC, Bogner HR, Gross R. Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence. Aids and Behavior. 14: 748-54. PMID 19089608 DOI: 10.1007/S10461-008-9502-1 |
0.365 |
|
| 2009 |
Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, Wiggins I, Hogg E, Flexner C, Mildvan D. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Archives of Internal Medicine. 169: 1224-32. PMID 19597072 DOI: 10.1001/Archinternmed.2009.172 |
0.395 |
|
| 2009 |
Gross R, Bisson GP. Evaluating the President's Emergency Plan for AIDS Relief: Time to Scale It Up Annals of Internal Medicine. 150: 727-728. PMID 19451581 DOI: 10.7326/0003-4819-150-10-200905190-00012 |
0.356 |
|
| 2009 |
Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, Montaner JSG. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. Journal of Acquired Immune Deficiency Syndromes. 50: 529-536. PMID 19223785 DOI: 10.1097/Qai.0B013E31819675E9 |
0.346 |
|
| 2008 |
Bisson GP, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. Journal of Acquired Immune Deficiency Syndromes. 49: 107-110. PMID 18667926 DOI: 10.1097/Qai.0B013E3181820141 |
0.396 |
|
| 2008 |
Gross R, Bilker WB, Wang H, Chapman J. How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? Hiv Clinical Trials. 9: 202-206. PMID 18547907 DOI: 10.1310/Hct0903-202 |
0.32 |
|
| 2008 |
Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB. Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy Plos Medicine. 5: 777-788. PMID 18494555 DOI: 10.1371/Journal.Pmed.0050109 |
0.354 |
|
| 2008 |
Lo Re V, Wertheimer B, Localio AR, Kostman JR, Dockter J, Linnen JM, Giachetti C, Dorey-Stein Z, Frank I, Strom BL, Gross R. Incidence of transaminitis among HIV-infected patients with occult hepatitis B. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 43: 32-6. PMID 18486540 DOI: 10.1016/J.Jcv.2008.03.030 |
0.331 |
|
| 2008 |
Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M, Avalos A, Friedman H, Dickinson D, Frank I, Ndwapi N. Overestimates of survival after HAART: implications for global scale-up efforts. Plos One. 3: e1725. PMID 18320045 DOI: 10.1371/Journal.Pone.0001725 |
0.342 |
|
| 2007 |
Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence Current Hiv/Aids Reports. 4: 187-191. PMID 18366950 DOI: 10.1007/S11904-007-0027-4 |
0.3 |
|
| 2007 |
Gross R. Predicting and monitoring antiretroviral adherence Ldi Issue Brief. 13: 1-4. PMID 18354853 |
0.319 |
|
| 2007 |
Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time Journal of Acquired Immune Deficiency Syndromes. 46: 323-327. PMID 17846560 DOI: 10.1097/Qai.0B013E31815724Fe |
0.428 |
|
| 2007 |
Gulick RM, Su Z, Flexner C, Hughes MD, Skolnik PR, Wilkin TJ, Gross R, Krambrink A, Coakley E, Greaves WL, Zolopa A, Reichman R, Godfrey C, Hirsch M, Kuritzkes DR, et al. Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211. The Journal of Infectious Diseases. 196: 304-12. PMID 17570119 DOI: 10.1086/518797 |
0.408 |
|
| 2007 |
Lo Re V, Frank I, Gross R, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients. Journal of Clinical Epidemiology. 60: 294-9. PMID 17292024 DOI: 10.1016/J.Jclinepi.2006.06.020 |
0.333 |
|
| 2007 |
Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 591-5. PMID 17243065 DOI: 10.1086/511035 |
0.388 |
|
| 2007 |
Lo Re V, Kostman JR, Gross R, Reddy KR, Mounzer K, Zemel BS, Rennert H, Stieritz DD, Putt M, Frank I, Strom BL. Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 344-50. PMID 17179767 DOI: 10.1097/Qai.0B013E31802F12D3 |
0.367 |
|
| 2007 |
Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 315-20. PMID 17159655 DOI: 10.1097/Qai.0B013E31802Ea499 |
0.335 |
|
| 2007 |
Graham J, Bennett IM, Holmes WC, Gross R. Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. Aids and Behavior. 11: 385-92. PMID 17053858 DOI: 10.1007/S10461-006-9164-9 |
0.409 |
|
| 2007 |
Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner CW, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM. Erratum: HIV type 1 chemokine co-receptor use among antiretroviral- experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211 (Clinical Infectious Diseases (2007) 44, (591-595)) Clinical Infectious Diseases. 44. DOI: 10.1086/518776 |
0.336 |
|
| 2006 |
Gross R, Yip B, Re VL, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JSG, Hogg RS. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. The Journal of Infectious Diseases. 194: 1108-1114. PMID 16991085 DOI: 10.1086/507680 |
0.433 |
|
| 2006 |
Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, Friedman H, Dickinson D, Frank I, Strom BL, Gaolathe T, Ndwapi N. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. Aids (London, England). 20: 1613-9. PMID 16868442 DOI: 10.1097/01.Aids.0000238407.00874.Dc |
0.343 |
|
| 2006 |
Bisson GP, Frank I, Gross R, Lo Re V, Strom JB, Wang X, Mogorosi M, Gaolathe T, Ndwapi N, Friedman H, Strom BL, Dickinson D. Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector. Aids (London, England). 20: 1333-6. PMID 16816566 DOI: 10.1097/01.Aids.0000232245.36039.2B |
0.383 |
|
| 2006 |
Papasavvas E, Kostman JR, Thiel B, Pistilli M, Mackiewicz A, Foulkes A, Gross R, Jordan KA, Nixon DF, Grant R, Poulin JF, McCune JM, Mounzer K, Montaner LJ. HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption. Journal of Clinical Immunology. 26: 40-54. PMID 16418802 DOI: 10.1007/S10875-006-7518-8 |
0.415 |
|
| 2005 |
Bisson GP, Strom BL, Gross R, Weissman D, Klinzman D, Hwang WT, Kostman JR, Metzger D, Stapleton JT, Frank I. Effect of GB virus C viremia on HIV acquisition and HIV set-point. Aids (London, England). 19: 1910-2. PMID 16227800 DOI: 10.1097/01.Aids.0000188427.25657.E7 |
0.421 |
|
| 2005 |
Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV Pharmacoepidemiology and Drug Safety. 14: 789-793. PMID 15880515 DOI: 10.1002/pds.1109 |
0.328 |
|
| 2004 |
Papasavvas E, Kostman JR, Mounzer K, Grant RM, Gross R, Gallo C, Azzoni L, Foulkes A, Thiel B, Pistilli M, Mackiewicz A, Shull J, Montaner LJ. Randomized, controlled trial of therapy interruption in chronic HIV-1 infection. Plos Medicine. 1. PMID 15630469 DOI: 10.1371/Journal.Pmed.0010064 |
0.418 |
|
| 2004 |
Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV Journal of Clinical Epidemiology. 57: 1107-1110. PMID 15528063 DOI: 10.1016/J.Jclinepi.2004.04.002 |
0.379 |
|
| 2004 |
Lo Re V, Gasink L, Kostman JR, Leonard D, Gross R. Natural history of patients with low-level HIV viremia on antiretroviral therapy. Aids Patient Care and Stds. 18: 436-42. PMID 15321015 DOI: 10.1089/1087291041703692 |
0.44 |
|
| 2003 |
Bisson G, Gross R, Miller V, Weller I, Walker A, Arlett P, Carr A, Evans S, Graham D, Justice A, Kreft-Jais C, Lundgren JD, Munk B, Murray J, Pirmohamed M, et al. Monitoring of long-term toxicities of HIV treatments: an international perspective. Aids (London, England). 17: 2407-17. PMID 14600511 DOI: 10.1097/00002030-200311210-00002 |
0.378 |
|
| 2003 |
Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression. The Journal of Infectious Diseases. 188: 873-82. PMID 12964119 DOI: 10.1086/377645 |
0.321 |
|
| 2002 |
Gross R. Adherence to HIV drug therapy Ldi Issue Brief. 8: 1-4. PMID 12530426 |
0.307 |
|
| 2002 |
Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy Aids. 16: 1835-1837. PMID 12218400 DOI: 10.1097/00002030-200209060-00021 |
0.339 |
|
| 2001 |
Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load Aids. 15: 2109-2117. PMID 11684930 DOI: 10.1097/00002030-200111090-00006 |
0.379 |
|
| 2000 |
Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, Moonis M, Sandberg JK, Drohan LA, Gallagher B, Shull J, Nixon DF, Kostman JR, Montaner LJ. Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption. The Journal of Infectious Diseases. 182: 766-75. PMID 10950770 DOI: 10.1086/315748 |
0.399 |
|
| Show low-probability matches. |